JAMA Authors Say Cost Shifting Likely Under Medicare Price Negotiation

Drug makers likely would charge employers and unions more for drugs if Congress directs Medicare to negotiate prices without making drug companies provide those prices to all insurers, according to authors of a Dec. 23 paper in the Journal of the American Medical Association. The paper, whose authors include former Clinton and Obama administration officials, seeks to referee the debate over cost shifting. Democrats’ drug pricing legislation, which is part of the Build Back Better bill, includes two primary...